Jian Liu

Title: Jian Liu: Innovator in Calcitonin and Amylin Receptor Modulation

Introduction

Jian Liu is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of calcitonin and amylin receptor activities. His innovative work has the potential to impact the treatment of various diseases associated with these receptors.

Latest Patents

Jian Liu holds a patent for "Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity." This patent provides compounds designed to modulate the activity of calcitonin and amylin receptors. Additionally, it includes pharmaceutical compositions that incorporate these compounds, along with methods for treating diseases or disorders linked to these receptors.

Career Highlights

Jian Liu is currently associated with Aconcagua Bio, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing unmet medical needs through novel therapeutic approaches.

Collaborations

Jian Liu collaborates with talented professionals in his field, including Hui Lei and Cui Li. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.

Conclusion

Jian Liu's contributions to the field of receptor modulation exemplify the impact of innovative thinking in pharmaceuticals. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of receptor-associated conditions.